PMC:7289100 / 42227-42477
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T136 | 153-158 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T319 | 111-112 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T320 | 153-158 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
| T321 | 171-172 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T180 | 20-31 | Chemical | denotes | tocilizumab | http://purl.obolibrary.org/obo/CHEBI_64360 |
| T181 | 73-79 | Chemical | denotes | oxygen | http://purl.obolibrary.org/obo/CHEBI_25805 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T258 | 0-250 | Sentence | denotes | Within 5 days after tocilizumab, 15 of the 20 patients had lowered their oxygen intake and 19 of the 20 showed a noticeable improvement in the CT of the lungs, as well as a significant reduction in CRP levels which was noted in 16 of the 19 patients. |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T576 | 20-31 | DG_35 | denotes | tocilizumab |
| T577 | 153-158 | UBERON:0000170 | denotes | lungs |
| T25449 | 20-31 | DG_35 | denotes | tocilizumab |
| T54606 | 153-158 | UBERON:0000170 | denotes | lungs |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1414 | 198-201 | Gene | denotes | CRP | Gene:1401 |
| 1418 | 46-54 | Species | denotes | patients | Tax:9606 |
| 1419 | 241-249 | Species | denotes | patients | Tax:9606 |
| 1422 | 20-31 | Chemical | denotes | tocilizumab | MESH:C502936 |
| 1423 | 73-79 | Chemical | denotes | oxygen | MESH:D010100 |